Treatment with Cellgevity® improves glycemic index and prevents atherogenic dyslipidemia in Type 2 Diabetic rat model. JHS [Internet]. 3 août 2025 [cité 10 nov. 2026];3(1):24-31. Disponible à: https://lasujournals.ng/index.php/jhs/article/view/75